Concepedia

Viral Vector Process Development

Viral Vector Process Development is a specialized methodology within biopharmaceutical process development that focuses on the systematic design, optimization, and scaling of production processes for viral vectors, distinguished by its application in gene therapy and vaccine platforms requiring precise control over vector yield, purity, and infectivity.

20

Publications

670

Citations

125

Authors

42

Institutions

Publications per year

2017–2026

13

Parents

Publications

20

Production of dengue 2 envelope domain III in plant using TMV-based vector system

Wanida Saejung, Kazuhito Fujiyama, Tomohiko Takasaki et al. · Vaccine · 2007 · 92 citations

, , +10

Manufacture of Third-Generation Lentivirus for Preclinical Use, with Process Development Considerations for Translation to Good Manufacturing Practice

Carolina Gándara, Valerie Affleck, Elizabeth A. Stoll · Human Gene Therapy Methods · 2017 · 88 citations · Full text

, , +17

Optimisation of a multipartite human immunodeficiency virus based vector system; control of virus infectivity and large-scale production

Rachel Koldej, Patricia Cmielewski, Alice G. Stocker et al. · The Journal of Gene Medicine · 2005 · 57 citations

, , +16

Bioprocess development for canine adenovirus type 2 vectors

P. Fernandes, Cristina Peixoto, Virgínia M. Santiago et al. · Gene Therapy · 2012 · 49 citations

, , +14

Process Development of Adenoviral Vector Production in Fixed Bed Bioreactor: From Bench to Commercial Scale

Hanna P. Lesch, Kati Heikkilä, Eevi M. Lipponen et al. · Human Gene Therapy · 2015 · 44 citations

, , +13

1–5 of 20

Authors

125

  1. HP
    Hanna P. Lesch

    University of Eastern Finland, Finland

    2 publications · 71 citations

    2

    h-index

  2. NP
    Nigel Parker

    University of Eastern Finland, Finland

    2 publications · 71 citations

    2

    h-index

  3. EM
    Eevi M. Lipponen

    University of Eastern Finland, Finland

    2 publications · 71 citations

    2

    h-index

  4. SY
    Seppo Ylä‐Herttuala

    University of Eastern Finland, Finland

    2 publications · 71 citations

    2

    h-index

  5. SL
    Shichong Li

    Chinese PLA General Hospital, China

    1 publications · 28 citations

    1

    h-index

1–5 of 125

Institutions

42

  1. University of Eastern Finland

    Joensuu, Finland

    2 h-index

    11 publications

    399 citations

  2. FinVector (Finland)

    Kuopio, Finland

    2 h-index

    18 publications

    673 citations

  3. Stuttgart Technical University of Applied Sciences

    Stuttgart, Germany

    1 h-index

    1 publications

    22 citations

  4. Biogen (United States)

    Cambridge, United States

    1 h-index

    4 publications

    48 citations

  5. Thermo Fisher Scientific (United States)

    Waltham, United States

    1 h-index

    1 publications

    17 citations

  6. École Pratique des Hautes Études

    Paris, France

    1 h-index

    2 publications

    46 citations

  7. Kuopio University Hospital

    Kuopio, Finland

    1 h-index

    1 publications

    44 citations

  8. The University of Adelaide

    Adelaide, Australia

    1 h-index

    4 publications

    228 citations

1–8 of 42

Venues

  1. Cell and Gene Therapy Insights

    3 publications · 65 citations

    3

    h-index

  2. Journal of Chromatography A

    2 publications · 46 citations

    2

    h-index

  3. Human Gene Therapy Methods

    2 publications · 111 citations

    2

    h-index

  4. Gene Therapy

    2 publications · 60 citations

    2

    h-index

  5. 2

    h-index

1–5